How big is the Neuropathic Pain Market?

The Neuropathic Pain Market size is expected to reach USD 7.29 billion in 2024 and grow at a CAGR of 9.74% to reach USD 11.60 billion by 2029. Read More

What is the current Neuropathic Pain Market size?

In 2024, the Neuropathic Pain Market size is expected to reach USD 7.29 billion. Read More

Who are the key players in Neuropathic Pain Market?

Grünenthal, Mallinckrodt Pharmaceuticals, Pfizer, Inc., Novartis AG and Teva Pharmaceutical Industries Ltd. are the major companies operating in the Neuropathic Pain Market. Read More

Which is the fastest growing region in Neuropathic Pain Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Neuropathic Pain Market?

In 2024, the North America accounts for the largest market share in Neuropathic Pain Market. Read More

What years does this Neuropathic Pain Market cover, and what was the market size in 2023?

In 2023, the Neuropathic Pain Market size was estimated at USD 6.58 billion. The report covers the Neuropathic Pain Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Neuropathic Pain Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Neuropathic Pain Market Share

Statistics for the 2023 & 2024 Neuropathic Pain market share, created by Mordor Intelligence™ Industry Reports. Neuropathic Pain share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Neuropathic Pain Industry

The neuropathic pain market is moderately competitive and consists of a few major players. Companies like Grünenthal, Mallinckrodt Pharmaceuticals, GlaxoSmithKline PLC, J Pfizer Inc., Cipla Inc., Glenmark, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd occupy a substantial market share.